Kent L. Kunze - Publications

Medicinal Chemistry University of Washington, Seattle, Seattle, WA 
Pharmaceutical Chemistry

46 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2014 Rock BM, Hengel SM, Rock DA, Wienkers LC, Kunze KL. Characterization of ritonavir-mediated inactivation of cytochrome P450 3A4. Molecular Pharmacology. 86: 665-74. PMID 25274602 DOI: 10.1124/Mol.114.094862  0.84
2014 Sager JE, Lutz JD, Foti RS, Davis C, Kunze KL, Isoherranen N. Fluoxetine- and norfluoxetine-mediated complex drug-drug interactions: in vitro to in vivo correlation of effects on CYP2D6, CYP2C19, and CYP3A4. Clinical Pharmacology and Therapeutics. 95: 653-62. PMID 24569517 DOI: 10.1038/Clpt.2014.50  0.84
2013 Lutz JD, VandenBrink BM, Babu KN, Nelson WL, Kunze KL, Isoherranen N. Stereoselective inhibition of CYP2C19 and CYP3A4 by fluoxetine and its metabolite: implications for risk assessment of multiple time-dependent inhibitor systems. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 41: 2056-65. PMID 23785064 DOI: 10.1124/Dmd.113.052639  0.84
2012 Fujioka Y, Kunze KL, Isoherranen N. Risk assessment of mechanism-based inactivation in drug-drug interactions. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 40: 1653-7. PMID 22685217 DOI: 10.1124/Dmd.112.046649  0.32
2012 Peng CC, Shi W, Lutz JD, Kunze KL, Liu JO, Nelson WL, Isoherranen N. Stereospecific metabolism of itraconazole by CYP3A4: dioxolane ring scission of azole antifungals. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 40: 426-35. PMID 22106171 DOI: 10.1124/Dmd.111.042739  0.84
2011 Woods CM, Fernandez C, Kunze KL, Atkins WM. Allosteric activation of cytochrome P450 3A4 by α-naphthoflavone: branch point regulation revealed by isotope dilution analysis. Biochemistry. 50: 10041-51. PMID 22004098 DOI: 10.1021/Bi2013454  0.84
2011 Peng CC, Templeton I, Thummel KE, Davis C, Kunze KL, Isoherranen N. Evaluation of 6β-hydroxycortisol, 6β-hydroxycortisone, and a combination of the two as endogenous probes for inhibition of CYP3A4 in vivo. Clinical Pharmacology and Therapeutics. 89: 888-95. PMID 21490593 DOI: 10.1038/Clpt.2011.53  0.32
2011 Babu KN, Kunze KL, Nelson WL. Metabolism of diltiazem: A short efficient synthesis of N, N -didesmethyldiltiazem - An important product of N-demethylation Synthesis. 553-554. DOI: 10.1055/S-0030-1258410  0.84
2010 Templeton I, Peng CC, Thummel KE, Davis C, Kunze KL, Isoherranen N. Accurate prediction of dose-dependent CYP3A4 inhibition by itraconazole and its metabolites from in vitro inhibition data. Clinical Pharmacology and Therapeutics. 88: 499-505. PMID 20739919 DOI: 10.1038/Clpt.2010.119  0.32
2010 Hanson KL, VandenBrink BM, Babu KN, Allen KE, Nelson WL, Kunze KL. Sequential metabolism of secondary alkyl amines to metabolic-intermediate complexes: opposing roles for the secondary hydroxylamine and primary amine metabolites of desipramine, (s)-fluoxetine, and N-desmethyldiltiazem. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 38: 963-72. PMID 20200233 DOI: 10.1124/Dmd.110.032391  0.84
2008 Templeton IE, Thummel KE, Kharasch ED, Kunze KL, Hoffer C, Nelson WL, Isoherranen N. Contribution of itraconazole metabolites to inhibition of CYP3A4 in vivo. Clinical Pharmacology and Therapeutics. 83: 77-85. PMID 17495874 DOI: 10.1038/Sj.Clpt.6100230  0.84
2007 Baer BR, Kunze KL, Rettie AE. Mechanism of formation of the ester linkage between heme and Glu310 of CYP4B1: 18O protein labeling studies. Biochemistry. 46: 11598-605. PMID 17880109 DOI: 10.1021/Bi701064B  0.84
2006 Pearson JT, Hill JJ, Swank J, Isoherranen N, Kunze KL, Atkins WM. Surface plasmon resonance analysis of antifungal azoles binding to CYP3A4 with kinetic resolution of multiple binding orientations. Biochemistry. 45: 6341-53. PMID 16700545 DOI: 10.1021/Bi0600042  0.32
2006 Kunze KL, Nelson WL, Kharasch ED, Thummel KE, Isoherranen N. Stereochemical aspects of itraconazole metabolism in vitro and in vivo. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 34: 583-90. PMID 16415110 DOI: 10.1124/Dmd.105.008508  0.84
2005 Cameron MD, Wen B, Allen KE, Roberts AG, Schuman JT, Campbell AP, Kunze KL, Nelson SD. Cooperative binding of midazolam with testosterone and alpha-naphthoflavone within the CYP3A4 active site: a NMR T1 paramagnetic relaxation study. Biochemistry. 44: 14143-51. PMID 16245930 DOI: 10.1021/Bi051689T  0.84
2005 Baer BR, Schuman JT, Campbell AP, Cheesman MJ, Nakano M, Moguilevsky N, Kunze KL, Rettie AE. Sites of covalent attachment of CYP4 enzymes to heme: evidence for microheterogeneity of P450 heme orientation. Biochemistry. 44: 13914-20. PMID 16229480 DOI: 10.1021/Bi051267J  0.84
2005 Regal KA, Kunze KL, Peter RM, Nelson SD. Oxidation of caffeine by CYP1A2: isotope effects and metabolic switching. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 33: 1837-44. PMID 16135658 DOI: 10.1124/Dmd.105.006031  0.84
2004 McConn DJ, Lin YS, Allen K, Kunze KL, Thummel KE. Differences in the inhibition of cytochromes P450 3A4 and 3A5 by metabolite-inhibitor complex-forming drugs. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 32: 1083-91. PMID 15377640 DOI: 10.1124/Dmd.32.10.1083  0.32
2004 Isoherranen N, Kunze KL, Allen KE, Nelson WL, Thummel KE. Role of itraconazole metabolites in CYP3A4 inhibition. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 32: 1121-31. PMID 15242978 DOI: 10.1124/Dmd.104.000315  0.84
2003 Neal JM, Kunze KL, Levy RH, O'Reilly RA, Trager WF. Kiiv, an in vivo parameter for predicting the magnitude of a drug interaction arising from competitive enzyme inhibition. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 31: 1043-8. PMID 12867493 DOI: 10.1124/Dmd.31.8.1043  0.84
2003 Yao C, Kunze KL, Trager WF, Kharasch ED, Levy RH. Comparison of in vitro and in vivo inhibition potencies of fluvoxamine toward CYP2C19. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 31: 565-71. PMID 12695344 DOI: 10.1124/Dmd.31.5.565  0.84
2003 Zheng YM, Baer BR, Kneller MB, Henne KR, Kunze KL, Rettie AE. Covalent heme binding to CYP4B1 via Glu310 and a carbocation porphyrin intermediate. Biochemistry. 42: 4601-6. PMID 12693958 DOI: 10.1021/Bi020667T  0.84
2002 Sachdeo RC, Sachdeo SK, Levy RH, Streeter AJ, Bishop FE, Kunze KL, Mather GG, Roskos LK, Shen DD, Thummel KE, Trager WF, Curtin CR, Doose DR, Gisclon LG, Bialer M. Topiramate and phenytoin pharmacokinetics during repetitive monotherapy and combination therapy to epileptic patients. Epilepsia. 43: 691-6. PMID 12102670 DOI: 10.1046/J.1528-1157.2002.41701.X  0.84
2001 Yao C, Kunze KL, Kharasch ED, Wang Y, Trager WF, Ragueneau I, Levy RH. Fluvoxamine-theophylline interaction: gap between in vitro and in vivo inhibition constants toward cytochrome P4501A2. Clinical Pharmacology and Therapeutics. 70: 415-24. PMID 11719727 DOI: 10.1067/Mcp.2001.119724  0.84
2001 Henne KR, Kunze KL, Zheng YM, Christmas P, Soberman RJ, Rettie AE. Covalent linkage of prosthetic heme to CYP4 family P450 enzymes. Biochemistry. 40: 12925-31. PMID 11669629 DOI: 10.1021/Bi011171Z  0.84
2000 Gibbs MA, Baillie MT, Shen DD, Kunze KL, Thummel KE. Persistent inhibition of CYP3A4 by ketoconazole in modified Caco-2 cells. Pharmaceutical Research. 17: 299-305. PMID 10801218 DOI: 10.1023/A:1007550717526  0.84
1998 Regal KA, Howald WN, Peter RM, Gartner CA, Kunze KL, Nelson SD. Subnanomolar quantification of caffeine's in vitro metabolites by stable isotope dilution gas chromatography-mass spectrometry. Journal of Chromatography. B, Biomedical Sciences and Applications. 708: 75-85. PMID 9653949 DOI: 10.1016/S0378-4347(97)00656-7  0.84
1997 Tran A, Rey E, Pons G, Rousseau M, d'Athis P, Olive G, Mather GG, Bishop FE, Wurden CJ, Labroo R, Trager WF, Kunze KL, Thummel KE, Vincent JC, Gillardin JM, et al. Influence of stiripentol on cytochrome P450-mediated metabolic pathways in humans: in vitro and in vivo comparison and calculation of in vivo inhibition constants. Clinical Pharmacology and Therapeutics. 62: 490-504. PMID 9390105 DOI: 10.1016/S0009-9236(97)90044-8  0.84
1997 Thummel KE, Kunze KL, Shen DD. Enzyme-catalyzed processes of first-pass hepatic and intestinal drug extraction Advanced Drug Delivery Reviews. 27: 99-127. DOI: 10.1016/S0169-409X(97)00039-2  0.84
1996 McHugh TE, Atkins WM, Rachal JK, Kunze KL, Eaton DL. Binding of the aflatoxin-glutathione conjugate to mouse glutathione S- transferase A3-3 is saturated at only one ligand per dimer Journal of Biological Chemistry. 271: 27470-27474. PMID 8910329 DOI: 10.1074/Jbc.271.44.27470  0.84
1996 Paine MF, Shen DD, Kunze KL, Perkins JD, Marsh CL, McVicar JP, Barr DM, Gillies BS, Thummel KE. First-pass metabolism of midazolam by the human intestine Clinical Pharmacology and Therapeutics. 60: 14-24. PMID 8689807 DOI: 10.1016/S0009-9236(96)90162-9  0.84
1996 Thummel KE, O'Shea D, Paine MF, Shen DD, Kunze KL, Perkins JD, Wilkinson GR. Oral first-pass elimination of midazolam involves both gastrointestinal and hepatic CYP3A-mediated metabolism Clinical Pharmacology and Therapeutics. 59: 491-502. PMID 8646820 DOI: 10.1016/S0009-9236(96)90177-0  0.84
1994 Neal JM, Howald WN, Kunze KL, Lawrence RF, Trager WF. Application of negative-ion chemical ionization isotope dilution gas chromatography-mass spectrometry to single-dose bioavailability studies of mefloquine Journal of Chromatography B: Biomedical Sciences and Applications. 661: 263-269. PMID 7894666 DOI: 10.1016/0378-4347(94)00371-8  0.84
1992 Rettie AE, Korzekwa KR, Kunze KL, Lawrence RF, Craig Eddy A, Aoyama T, Gelboin HV, Gonzalez FJ, Trager WF. Hydroxylation of warfarin by human cDNA-expressed cytochrome P-450: A role for P-4502C9 in the etiology of (S)-warfarin - Drug interactions Chemical Research in Toxicology. 5: 54-59. PMID 1581537 DOI: 10.1021/Tx00025A009  0.84
1983 Kunze KL, Ortiz de Montellano PR. Formation of a .sigma.-bonded aryliron complex in the reaction of arylhydrazines with hemoglobin and myoglobin Journal of the American Chemical Society. 105: 1380-1381. DOI: 10.1021/Ja00343A057  0.4
1982 Ortiz de Montellano PR, Kunze KL. Cytochrome P-450 inactivation: structure of the prosthetic heme adduct with propyne. Biochemistry. 20: 7266-71. PMID 7317380 DOI: 10.1021/Bi00528A033  0.64
1982 Ortiz de Montellano PR, Kunze KL, Beilan HS, Wheeler C. Destruction of cytochrome P-450 by vinyl fluoride, fluroxene, and acetylene. Evidence for a radical intermediate in olefin oxidation. Biochemistry. 21: 1331-9. PMID 6122467 DOI: 10.1021/Bi00535A035  0.56
1982 Ortiz de Montellano PR, Kunze KL, Augusto O. Hemoprotein destruction. Iron-nitrogen shift of a phenyl group in a porphyrin complex Journal of the American Chemical Society. 104: 3545-3546. DOI: 10.1021/Ja00376A069  0.44
1981 Ortiz de Montellano PR, Kunze KL. Shift of the acetylenic hydrogen during chemical and enzymatic oxidation of the biphenylacetylene triple bond. Archives of Biochemistry and Biophysics. 209: 710-2. PMID 7294821 DOI: 10.1016/0003-9861(81)90333-7  0.68
1981 Ortiz de Montellano PR, Beilan HS, Kunze KL. N-Methylprotoporphyrin IX: chemical synthesis and identification as the green pigment produced by 3,5-diethoxycarbonyl-1,4-dihydrocollidine treatment. Proceedings of the National Academy of Sciences of the United States of America. 78: 1490-4. PMID 6940170 DOI: 10.1073/pnas.78.3.1490  0.72
1981 Ortiz de Montellano PR, Kunze KL, Cole SP, Marks GS. Inhibition of hepatic ferrochelatase by the four isomers of N-methylprotoporphyrin IX. Biochemical and Biophysical Research Communications. 97: 1436-42. PMID 6894236 DOI: 10.1016/S0006-291X(80)80026-X  0.4
1981 Ortiz de Montellano PR, Kunze KL. Formation of N-phenylheme in the hemolytic reaction of phenylhydrazine with hemoglobin Journal of the American Chemical Society. 103: 6534-6536. DOI: 10.1021/Ja00411A061  0.44
1981 Kunze KL, Ortiz de Montellano PR. N-Methylprotoporphyrin IX. Identification by NMR of the nitrogen alkylated in each of the four isomers Journal of the American Chemical Society. 103: 4225-4230. DOI: 10.1021/Ja00404A042  0.36
1980 Ortiz de Montellano PR, Kunze KL. Inactivation of hepatic cytochrome P-450 by allenic substrates. Biochemical and Biophysical Research Communications. 94: 443-9. PMID 7396909 DOI: 10.1016/0006-291X(80)91251-6  0.6
1980 Porter WR, Kunze K, Valente EJ, Trager WF. The synthesis of C-2 isotopically labeled optically pure warfarin and phenprocoumon Journal of Labelled Compounds and Radiopharmaceuticals. 17: 763-773. DOI: 10.1002/Jlcr.2580170602  0.84
1979 Ortiz De Montellano PR, Kunze KL, Yost GS, Mico BA. Self-catalyzed destruction of cytochrome P-450: Covalent binding of ethynyl sterols to prosthetic heme Proceedings of the National Academy of Sciences of the United States of America. 76: 746-749. PMID 284396 DOI: 10.1073/pnas.76.2.746  0.84
Show low-probability matches.